Cargando…
Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome
The metabolic syndrome (MetS) is highly prevalent and confers an increased risk of diabetes and cardiovascular disease. A key early event in atherosclerosis is endothelial dysfunction. Numerous groups have reported endothelial dysfunction in MetS. However, the measurement of endothelial function is...
Autores principales: | Devaraj, Sridevi, Jialal, Ishwarlal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176409/ https://www.ncbi.nlm.nih.gov/pubmed/21941528 http://dx.doi.org/10.1155/2012/585018 |
Ejemplares similares
-
Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?
por: Devaraj, Sridevi, et al.
Publicado: (2010) -
Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome
por: Jialal, Ishwarlal, et al.
Publicado: (2023) -
Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome
por: Devaraj, Sridevi, et al.
Publicado: (2010) -
Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323
por: Jialal, Ishwarlal, et al.
Publicado: (2014) -
AHA/ACC/Multisociety Cholesterol Guidelines:
highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)